BERLIN (AP) â Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
The Germany-based company, which developed the first widely approved coronavirus shot together with U.S. partner Pfizer, aims to begin clinical trials for a âsafe and highly effective malaria vaccineâ by the end of next year.
âWe are already working on HIV and and tuberculosis, and malaria is the third big indication (disease) with a high unmet medical need,â BioNTech s chief executive, Ugur Sahin, told The Associated Press. âIt has an incredible high number of people being infected every year, a high number of patients dying, a particularly severe disease and high mortality in small children.â
Vaccine Maker Targets Malaria
manufacturing.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manufacturing.net Daily Mail and Mail on Sunday newspapers.
Vaccine Maker Targets Malaria
mbtmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mbtmag.com Daily Mail and Mail on Sunday newspapers.